Sherman Asset Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Sherman Asset Management's LLY Position: Q2 2026 in Review
Sherman Asset Management reduced its Eli Lilly (LLY) stake by 24% in Q2 2026, selling an estimated $213K and leaving 657 shares worth $788K. The position accounts for 0.61% of the portfolio, ranked #27.
Sherman Asset Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. The position peaked at $4.64M in Q4 2024. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Sherman Asset Management held 657 shares of Eli Lilly worth $788K as of Q2 2026.
- Sherman Asset Management sold 208 Eli Lilly shares in Q2 2026, an estimated $213K.
- Eli Lilly made up 0.61% of Sherman Asset Management's portfolio in Q2 2026, its #27 holding.
- Sherman Asset Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
- Sherman Asset Management's Eli Lilly position peaked at $4.64M in Q4 2024.
- 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Sherman Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.